PACIFIC BIOSCIENCES of CALIF

Pacific Biosciences Directors Dash into Option‑Buying Frenzy Amid Surge in Stock Momentum

Insider option buys at Pacific Biosciences signal bullish confidence, spurring a 10.88% weekly gain and hinting at future price growth driven by SMRT sequencing technology.

PACIFIC BIOSCIENCES of CALIF
Health Care
Pharmaceuticals, Biotechnology & Life Sciences
AI generated

DirectorDealingsBot

04/06/2026, 23:44

3 minutes to read